Emergency tablet for heart attack
Pro Research Analysisby 
Searched over 200M research papers
Emergency Tablets for Heart Attack: A Comprehensive Overview
Introduction to Emergency Heart Attack Medications
Heart attacks, or myocardial infarctions, are critical medical emergencies that require immediate intervention. Various medications and devices have been developed to provide rapid treatment during such events. This article explores the latest advancements in emergency tablets and related technologies for heart attack management.
Acetylsalicylic Acid (ASA) and Nitroglycerin: Essential Emergency Medications
Importance of ASA and Nitroglycerin
Guidelines recommend that patients with coronary artery disease (CAD) carry acetylsalicylic acid (ASA) and sublingual nitroglycerin to use at the onset of chest pain. These medications are crucial for preventing further cardiac damage and improving survival rates1.
SMHeartCard: A Compact Storage Solution
To address the issue of poor compliance with carrying these medications, researchers developed the SMHeartCard, a compact, on-person storage device. This device is designed to hold four 81-mg ASA tablets and three 0.3-mg Nitrostat (nitroglycerin) tablets. The SMHeartCard ensures the stability of nitroglycerin tablets across a wide range of temperatures, making it a reliable option for emergency use1.
Promoting ASA Use During Heart Attacks
Public Awareness and Packaging
Despite the life-saving potential of ASA during a heart attack, public awareness remains low. A proposed solution is to package single-dose ASA tablets with clear, life-saving instructions and a recognizable first aid symbol. This approach aims to make ASA more accessible and encourage its use during emergencies2.
Nifekalant: A Novel Anti-Arrhythmic Agent
Efficacy in Life-Threatening Arrhythmias
Nifekalant, a class III anti-arrhythmic agent, has shown promise in treating life-threatening ventricular tachyarrhythmias (VT) and ventricular fibrillation (VF). In a study involving 191 patients, nifekalant successfully terminated VT/VF in a significant number of cases, either directly or in combination with direct-current (DC) shock3. This medication offers a valuable option for emergency treatment of severe arrhythmias.
Clopidogrel Bisulfate: Chronotherapy for Heart Attack Prevention
High-Density Gastroretentive Tablets
Clopidogrel bisulfate (CLB) is an antiplatelet agent used to prevent heart attacks. Researchers have developed a novel high-density tablet designed for prolonged gastric retention, ensuring timely drug release during morning hours when heart attacks are more likely to occur. This pulsatile release system enhances the effectiveness of CLB in preventing heart attacks5.
Epinephrine: The First-Line Emergency Drug
Meta-Analysis of Efficacy and Safety
Epinephrine remains the first-line drug for cardiac arrest and anaphylactic reactions. A meta-analysis of 12 clinical trials involving over 200,000 patients confirmed the efficacy and safety of epinephrine in both out-of-hospital and in-hospital settings. The analysis strongly supports the use of epinephrine as a critical emergency medication6.
Medical Drones: Innovative AED Delivery
Enhancing Access to Defibrillators
Automated external defibrillators (AEDs) significantly improve survival rates in sudden cardiac arrest cases. However, AED availability is limited, especially in residential areas. A novel solution involves using medical drones to deliver AEDs to the patient's location. This system, tested successfully in simulations, ensures rapid access to life-saving equipment, potentially transforming emergency response7.
Conclusion
Emergency tablets and related technologies play a vital role in heart attack management. Innovations such as the SMHeartCard, nifekalant, high-density CLB tablets, and medical drones for AED delivery are enhancing the effectiveness and accessibility of emergency treatments. Public awareness and proper packaging of ASA can further improve outcomes during heart attacks. These advancements collectively contribute to better preparedness and response in cardiac emergencies.
Sources and full results
Most relevant research papers on this topic
Development and validation of a compact on-person storage device (SMHeartCard) for emergency access to acetylsalicylic acid and nitroglycerin.
The SMHeartCard, a compact on-person storage device for emergency cardiac medications, maintains long-term performance and provides immediate access under various conditions.
Soundings: This tablet may save your life
Pharmaceutical companies should produce brightly packaged single dose aspirin tablets with the slogan "This tablet could save your life if taken as soon as possible during a heart attack," along with a tick list of important contraindications.
Emergency treatment with nifekalant, a novel class III anti-arrhythmic agent, for life-threatening refractory ventricular tachyarrhythmias: post-marketing special investigation.
Nifekalant is effective and useful for life-threatening refractory ventricular tachyarrhythmias, but careful monitoring of the QT interval is necessary.
Observational StudyIntervening on fear after acute cardiac events: Rationale and design of the INFORM randomized clinical trial.
Targeting fear of recurrence or future time perspective through cognitive bias modification training may improve medication adherence and physical activity in acute coronary syndrome patients.
RCTDevelopment of Novel High Density Gastroretentive Multiparticulate Pulsatile Tablet of Clopidogrel Bisulfate Using Quality by Design Approach
The novel high density tablet with multiparticulate pellets and pulsatile release of Clopidogrel bisulfate provides stable gastric retention and chronotheraupetic activity for heart attack prevention.
Is epinephrine still the drug of choice during cardiac arrest in the emergency department of the hospital? A meta-analysis
Epinephrine injection remains the first-line cardiac emergency drug for both out-of-hospital and in-hospital cardiac arrest patients, with strong evidence supporting its efficacy and safety.
Meta-AnalysisMedical Drone Managing System for Automated External Defibrillator Delivery Service
The developed medical drone managing system can effectively deliver an AED in an emergency, potentially increasing survival rates in sudden cardiac arrest patients.
Effectiveness of a Novel Tablet Application in Reducing Guideline Deviations During Pediatric Cardiac Arrest
The use of a tablet application cognitive aid improves adherence to resuscitation guidelines during pediatric cardiac arrest, potentially leading to better patient outcomes.
Myocardial Infarction: Symptoms and Treatments
Myocardial infarction (MI) is caused by plaques in arteries, and immediate treatment includes aspirin, nitroglycerin, and thrombolytic drugs.
Highly Cited